Cargando…
De Novo Complement-Binding Anti-HLA Antibodies in Heart Transplanted Patients Is Associated with Severe Cardiac Allograft Vasculopathy and Poor Long-Term Survival
Introduction: De novo anti-HLA donor specific antibodies (DSA) have been inconsistently associated with cardiac allograft vasculopathy (CAV) and long-term mortality. We tested whether C3d-binding de novo DSA were associated with CAV or long-term-survival. Methods: We included 282 consecutive patient...
Autores principales: | Baudry, Guillaume, Pozzi, Matteo, Aubry, Matthieu, Hugon-Vallet, Elisabeth, Mocan, Raluca, Chalabreysse, Lara, Portran, Philippe, Obadia, Jean-François, Thaunat, Olivier, Girerd, Nicolas, Dubois, Valérie, Sebbag, Laurent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9267850/ https://www.ncbi.nlm.nih.gov/pubmed/35807015 http://dx.doi.org/10.3390/jcm11133731 |
Ejemplares similares
-
Prognosis of Advanced Heart Failure Patients according to Their Hemodynamic Profile Based on the Modified Forrester Classification
por: Baudry, Guillaume, et al.
Publicado: (2022) -
Haemodynamic parameters associated with renal function prior to and following heart transplantation
por: Baudry, Guillaume, et al.
Publicado: (2021) -
Outcome Predictors and Safety of Home Dobutamine Intravenous Infusion in End Stage Heart Failure Patients
por: Jobbé-Duval, Antoine, et al.
Publicado: (2021) -
Risk factors of cardiac allograft vasculopathy
por: Szyguła-Jurkiewicz, Bożena, et al.
Publicado: (2015) -
Everolimus-Eluting Second-Generation Stents for Treatment of De Novo Lesions in Patients with Cardiac Allograft Vasculopathy
por: Pyka, Łukasz, et al.
Publicado: (2020)